Retinoids as chemoprevention for head and neck cancer: where do we go from here?
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 55 (2) , 143-152
- https://doi.org/10.1016/j.critrevonc.2005.02.003
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Retinoids in cancer therapy and chemoprevention: promise meets resistanceOncogene, 2003
- Recent developments of retinoids as therapeutic agentsExpert Opinion on Therapeutic Patents, 2002
- Chemoprevention of Aerodigestive Tract CancersAnnual Review of Medicine, 2002
- Redox Control of Retinoic Acid Receptor Activity: A Novel Mechanism for Retinoic Acid Resistance in Melanoma CellsEndocrinology, 2001
- DNA Content as a Prognostic Marker in Patients with Oral LeukoplakiaNew England Journal of Medicine, 2001
- Low-Dose Isotretinoin Versus -Carotene to Prevent Oral Carcinogenesis: Long-term Follow-upJNCI Journal of the National Cancer Institute, 1997
- Prevention of second primary tumours with a second generation retinoid in squamous cell carcinoma of oral cavity and oropharynx: Long term follow-upEuropean Journal Of Cancer, 1996
- Suppression of Retinoic Acid Receptor–β in Premalignant Oral Lesions and Its Up-Regulation by IsotretinoinNew England Journal of Medicine, 1995
- Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neckCurrent Opinion in Oncology, 1995
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986